Department of Pharmacology (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, P. R. China.
Center for Drug Research and Development, Guangdong Pharmaceutical University, Guangzhou, P. R. China.
J Cell Mol Med. 2020 Sep;24(17):9545-9559. doi: 10.1111/jcmm.15363. Epub 2020 Jul 28.
RNF4, a poly-SUMO-specific E3 ubiquitin ligase, is associated with protein degradation, DNA damage repair and tumour progression. However, the effect of RNF4 in cardiomyocytes remains to be explored. Here, we identified the alteration of RNF4 from ischaemic hearts and oxidative stress-induced apoptotic cardiomyocytes. Upon myocardial infarction (MI) or H O /ATO treatment, RNF4 increased rapidly and then decreased gradually. PML SUMOylation and PML nuclear body (PML-NB) formation first enhanced and then degraded upon oxidative stress. Reactive oxygen species (ROS) inhibitor was able to attenuate the elevation of RNF4 expression and PML SUMOylation. PML overexpression and RNF4 knockdown by small interfering RNA (siRNA) enhanced PML SUMOylation, promoted p53 recruitment and activation and exacerbated H O /ATO-induced cardiomyocyte apoptosis which could be partially reversed by knockdown of p53. In vivo, knockdown of endogenous RNF4 via in vivo adeno-associated virus infection deteriorated post-MI structure remodelling including more extensive interstitial fibrosis and severely fractured and disordered structure. Furthermore, knockdown of RNF4 worsened ischaemia-induced cardiac dysfunction of MI models. Our results reveal a novel myocardial apoptosis regulation model that is composed of RNF4, PML and p53. The modulation of these proteins may provide a new approach to tackling cardiac ischaemia.
RNF4 是一种多聚 SUMO 特异性 E3 泛素连接酶,与蛋白降解、DNA 损伤修复和肿瘤进展有关。然而,RNF4 在心肌细胞中的作用仍有待探索。在这里,我们鉴定了缺血性心脏和氧化应激诱导的凋亡心肌细胞中 RNF4 的变化。在心肌梗死(MI)或 H2O2/ATO 处理后,RNF4 迅速增加,然后逐渐减少。PML SUMO 化和 PML 核体(PML-NB)形成在氧化应激下首先增强,然后降解。活性氧(ROS)抑制剂能够减弱 RNF4 表达和 PML SUMO 化的升高。PML 的过表达和 RNF4 的小干扰 RNA(siRNA)敲低增强了 PML SUMO 化,促进了 p53 的募集和激活,并加剧了 H2O2/ATO 诱导的心肌细胞凋亡,而 p53 的敲低可以部分逆转这一作用。在体内,通过体内腺相关病毒感染敲低内源性 RNF4 会恶化 MI 后结构重塑,包括更广泛的间质纤维化和严重断裂和紊乱的结构。此外,RNF4 的敲低会使 MI 模型的缺血性心脏功能恶化。我们的结果揭示了一个由 RNF4、PML 和 p53 组成的新的心肌细胞凋亡调控模型。这些蛋白的调节可能为治疗心脏缺血提供一种新方法。